Targeted therapy for patients with renal-cell carcinoma

Jenny J. Kim, Susan A.J. Vaziri, Brian I. Rini, Paul Elson, Jorge A. Garcia, Robert Wirka, Robert Dreicer, Mahrukh K. Ganapathi, Ram Ganapathi, Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib Cancer. ,vol. 118, pp. 1946- 1954 ,(2012) , 10.1002/CNCR.26491

Brian I Rini, Bernard Escudier, Steven C Campbell, Renal Cell Carcinoma ,(2009)

Farida Latif, Kalman Tory, James Gnarra, Masahiro Yao, Fuh-Mei Duh, Mary Lou Orcutt, Thomas Stackhouse, Igor Kuzmin, William Modi, Laura Geil, Laura Schmidt, Fangwei Zhou, Hua Li, Ming Hui Wei, Fan Chen, Gladys Glenn, Peter Choyke, McClellan M Walther, Yongkai Weng, Dah-Shuhn R Duan, Michael Dean, Damjan Glavač, Frances M Richards, Paul A Crossey, Malcolm A Ferguson-Smith, Denis Le Paslier, llya Chumakov, Daniel Cohen, A Craig Chinault, Eamonn R Maher, W Marston Linehan, Berton Zbar, Michael I Lerman, Identification of the von Hippel-Lindau disease tumor suppressor gene Science. ,vol. 260, pp. 1317- 1320 ,(1993) , 10.1126/SCIENCE.8493574

Chun-Fang Xu, Nan X Bing, Howard A Ball, Dilip Rajagopalan, Cora N Sternberg, Thomas E Hutson, Paul de Souza, Zhengyu G Xue, Lauren McCann, Karen S King, Leigh J Ragone, John C Whittaker, Colin F Spraggs, Lon R Cardon, Vincent E Mooser, Lini N Pandite, None, Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes Journal of Clinical Oncology. ,vol. 29, pp. 2557- 2564 ,(2011) , 10.1200/JCO.2010.32.9110

Nielka P. van Erp, Karel Eechoute, Astrid A. van der Veldt, John B. Haanen, An K.L. Reyners, Ron H.J. Mathijssen, Epie Boven, Tahar van der Straaten, Renée F. Baak-Pablo, Judith A.M. Wessels, Henk-Jan Guchelaar, Hans Gelderblom, Pharmacogenetic Pathway Analysis for Determination of Sunitinib-Induced Toxicity Journal of Clinical Oncology. ,vol. 27, pp. 4406- 4412 ,(2009) , 10.1200/JCO.2008.21.7679

Jesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, Daniel E Castellano, Aranzazu González del Alba, Miguel Angel Climent, José Angel Arranz, Enrique Gallardo, Javier Puente, Joaquim Bellmunt, Begoña Mellado, Esther Martínez, Fernando Moreno, Albert Font, Mercedes Robledo, Cristina Rodríguez-Antona, Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study Lancet Oncology. ,vol. 12, pp. 1143- 1150 ,(2011) , 10.1016/S1470-2045(11)70266-2

B. I. Rini, D. P. Cohen, D. R. Lu, I. Chen, S. Hariharan, M. E. Gore, R. A. Figlin, M. S. Baum, R. J. Motzer, Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib Journal of the National Cancer Institute. ,vol. 103, pp. 763- 773 ,(2011) , 10.1093/JNCI/DJR128

Astrid A.M. van der Veldt, Karel Eechoute, Hans Gelderblom, Jourik Gietema, Henk-Jan Guchelaar, Nielka P. van Erp, Alfons J.M. van den Eertwegh, John B. Haanen, Ron H.J. Mathijssen, Judith A.M. Wessels, Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib Clinical Cancer Research. ,vol. 17, pp. 620- 629 ,(2011) , 10.1158/1078-0432.CCR-10-1828